Hong Truong, MD, MS - Penn State Cancer Institute
Researcher Profile
Hong Truong, MD, MS
Assistant Professor, Department of Urology
Scientific Program:Cancer Control
Clinical Trials
Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE)
A Phase II/III trial of Durvalumab and Chemotherapy for Patients with High Grade Upper Tract Urothelial Cancer Prior to Nephroureterectomy EA8192
A Phase 3, Randomized Study of Adjuvant Cretostimogene Grenadenorepvec versus Observation for the Treatment of Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR-NMIBC) Following Transurethral Resection of Bladder Tumor (TURBT)
Recent Publications
2024
Zhang, Y, Wu, Q, Warrick, JI, DeGraff, DJ, Raman, JD, Truong, H & Chen, G 2024, 'Clinicopathological risk factors associated with tumor relapse of upper tract urothelial carcinoma after radical nephroureterectomy: A single institution 20-year experience', Annals of Diagnostic Pathology, vol. 73, 152357. https://doi.org/10.1016/j.anndiagpath.2024.152357
Lenis, AT, Ravichandran, V, Brown, S, Alam, SM, Katims, A, Truong, H, Reisz, PA, Vasselman, S, Nweji, B, Autio, KA, Morris, MJ, Slovin, SF, Rathkopf, D, Danila, D, Woo, S, Vargas, HA, Laudone, VP, Ehdaie, B, Reuter, V, Arcila, M, Berger, MF, Viale, A, Scher, HI, Schultz, N, Gopalan, A, Donoghue, MTA, Ostrovnaya, I, Stopsack, KH, Solit, DB & Abida, W 2024, 'Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer', Clinical Cancer Research, vol. 30, no. 17, pp. 3894-3903. https://doi.org/10.1158/1078-0432.CCR-23-3403
Lenis, AT, Whiting, K, Ravichandran, V, Tallman, JE, Alam, SM, Chu, CE, Jesus Escano, MD, Bochner, E, Katims, A, Reisz, PA, Truong, H, Clinton, TN, Telis, L, Dason, S, McPherson, V, Teo, MY, Funt, S, Aggen, D, Goh, AC, Donahue, TF, Cha, EK, Donat, SM, Herr, HW, Dalbagni, G, Schultz, N, Berger, MF, Bajorin, DF, Rosenberg, JE, Bochner, BH, Ostrovnaya, I, Al-Ahmadie, H, Solit, DB, Iyer, G & Pietzak, EJ 2024, 'Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer', JCO Precision Oncology, vol. 8, e2300274. https://doi.org/10.1200/PO.23.00274
2023
Khaleel, S, Truong, H, Jiang, S, K-Lee, P, Davelman, B, Gordon, D, Benfante, N, Arora, A, Ostrovnaya, I, Tickoo, S, Coleman, J, Hakimi, AA & Russo, P 2023, 'Adverse pathologic features impact survival outcomes for small renal masses following nephrectomy', Urologic Oncology: Seminars and Original Investigations, vol. 41, no. 9, pp. 391.e5-391.e11. https://doi.org/10.1016/j.urolonc.2023.06.010
Truong, H, Breen, K, Nandakumar, S, Sjoberg, DD, Kemel, Y, Mehta, N, Lenis, AT, Reisz, PA, Carruthers, J, Benfante, N, Joseph, V, Khurram, A, Gopalan, A, Fine, SW, Reuter, VE, Vickers, AJ, Birsoy, O, Liu, Y, Walsh, M, Latham, A, Mandelker, D, Stadler, ZK, Pietzak, E, Ehdaie, B, Touijer, KA, Laudone, VP, Slovin, SF, Autio, KA, Danila, DC, Rathkopf, DE, Eastham, JA, Chen, Y, Morris, MJ, Offit, K, Solit, DB, Scher, HI, Abida, W, Robson, ME & Carlo, MI 2023, 'Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer', European Urology, vol. 83, no. 1, pp. 29-38. https://doi.org/10.1016/j.eururo.2022.08.028
2022
Truong, H & Carlo, MI 2022, Hereditary Cancer and Genetics in Renal Cell Carcinoma. in Urologic Oncology: Multidisciplinary Care for Patients. Springer International Publishing, pp. 285-298. https://doi.org/10.1007/978-3-030-89891-5_14
Pietzak, EJ, Whiting, K, Srinivasan, P, Bandlamudi, C, Khurram, A, Joseph, V, Walasek, A, Bochner, E, Clinton, T, Almassi, N, Truong, H, de Jesus Escano, MR, Wiseman, M, Mandelker, D, Kemel, Y, Zhang, L, Walsh, MF, Cadoo, KA, Coleman, JA, Al-Ahmadie, H, Rosenberg, JE, Iyer, GV, Solit, DB, Ostrovnaya, I, Offit, K, Robson, ME, Stadler, ZK, Berger, MF, Bajorin, DF, Carlo, M & Bochner, BH 2022, 'Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder Cancer', Clinical Cancer Research, vol. 28, no. 19, pp. 4267-4277. https://doi.org/10.1158/1078-0432.CCR-22-1006
Funt, SA, Lattanzi, M, Whiting, K, Al-Ahmadie, H, Quinlan, C, Teo, MY, Lee, CH, Aggen, D, Zimmerman, D, Mchugh, D, Apollo, A, Durdin, TD, Truong, H, Kamradt, J, Khalil, M, Lash, B, Ostrovnaya, I, Mccoy, AS, Hettich, G, Regazzi, A, Jihad, M, Ratna, N, Boswell, A, Francese, K, Yang, Y, Folefac, E, Herr, HW, Donat, SM, Pietzak, E, Cha, EK, Donahue, TF, Goh, AC, Huang, WC, Bajorin, DF, Iyer, G, Bochner, BH, Balar, AV, Mortazavi, A & Rosenberg, JE 2022, 'Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial', Journal of Clinical Oncology, vol. 40, no. 12, pp. 1312-1322. https://doi.org/10.1200/JCO.21.01485
Truong, H, Sheikh, R, Kotecha, R, Kemel, Y, Reisz, PA, Lenis, AT, Mehta, NN, Khurram, A, Joseph, V, Mandelker, D, Latham, A, Ceyhan-Birsoy, O, Ladanyi, M, Dhah, NJ, Walsh, MF, Voss, MH, Lee, CH, Russo, P, Coleman, JA, Hakimi, AA, Feldman, DR, Stadler, ZK, Robson, ME, Motzer, RJ, Offit, K, Patil, S & Carlo, MI 2022, 'Re: Germline Variants Identified in Patients with Early-Onset Renal Cell Carcinoma Referred for Germline Genetic Testing', Journal of Urology, vol. 207, no. 5, pp. 1151-1152. https://doi.org/10.1097/JU.0000000000002471
Ramotar, M, Chua, MLK, Truong, H, Hosni, A, Pintilie, M, Davicioni, E, Fleshner, NE, Dicker, AP, Bristow, RG, He, HH, van der Kwast, T, Den, RB & Berlin, A 2022, 'Subpathologies and genomic classifier for treatment individualization of post-prostatectomy radiotherapy', Urologic Oncology: Seminars and Original Investigations, vol. 40, no. 1, pp. 5.e1-5.e13. https://doi.org/10.1016/j.urolonc.2021.08.013
Katims, AB, Reisz, PA, Nogueira, L, Truong, H, Lenis, AT, Pietzak, EJ, Kim, K & Coleman, JA 2022, 'Targeted Therapies in Advanced and Metastatic Urothelial Carcinoma', Cancers, vol. 14, no. 21, 5431. https://doi.org/10.3390/cancers14215431
Kucherov, V, Truong, H, Raab, C & Hagerty, JA 2022, 'Urologic Presentations and Management Options in Pediatric Mitochondrial Disease', Urology, vol. 164, pp. 230-237. https://doi.org/10.1016/j.urology.2021.12.023
2021
Truong, H, Sheikh, R, Kotecha, R, Kemel, Y, Reisz, PA, Lenis, AT, Mehta, NN, Khurram, A, Joseph, V, Mandelker, D, Latham, A, Ceyhan-Birsoy, O, Ladanyi, M, Shah, NJ, Walsh, MF, Voss, MH, Lee, CH, Russo, P, Coleman, JA, Hakimi, AA, Feldman, DR, Stadler, ZK, Robson, ME, Motzer, RJ, Offit, K, Patil, S & Carlo, MI 2021, 'Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing', European Urology Oncology, vol. 4, no. 6, pp. 993-1000. https://doi.org/10.1016/j.euo.2021.09.005
Truong, H, Maxon, V & Goh, AC 2021, 'Robotic Female Radical Cystectomy', Journal of Endourology, vol. 35, no. S2, pp. S106-S115. https://doi.org/10.1089/end.2020.1190
Truong, H & Figler, BD 2021, Traumatic adrenal hemorrhage. in A Clinical Guide to Urologic Emergencies. wiley, pp. 83-90. https://doi.org/10.1002/9781119021506.ch5